{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:39:38Z","timestamp":1792481978184,"version":"4.5.0"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006285","name":"Magnus Bergvalls Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006285","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006353","name":"Kjell och M\u00e4rta Beijers Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006353","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The illicit use of anabolic androgenic steroids (AAS) to enhance physical strength, performance, and appearance is associated with severe physical and psychological adverse effects. Long-term AAS use has been associated with altered behavior and cognitive impairments. Nevertheless, the neurobiological effects of AAS use remain underexplored, especially in terms of brain neurotransmitter and lipid profiles. This study applied advanced Fourier-transform ion cyclotron resonance matrix-assisted laser desorption\/ionization mass spectrometry imaging (FTICR-MALDI-MSI) to investigate the effects of three AAS decanoate prodrugs, nandrolone, testosterone, and trenbolone, on brain monoamine neurotransmitter systems and lipid composition in male rats (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200932). The AAS administration was found to alter dopamine and serotonin levels, as well as the metabolism of these molecules across multiple brain regions; significant effects on neurotransmitter levels, associated metabolites, and turnover ratios were observed. Additionally, AAS treatment affected brain lipid composition, with nandrolone and testosterone increasing the levels of phosphatidylethanolamines, ether-linked phosphatidylethanolamines, and phosphatidylserines; in contrast, trenbolone demonstrated an opposite trend. The presented findings revealed distinct, steroid-specific alterations in brain neurotransmitters and lipid profiles; these changes were particularly strong in the tail of the striatum, where lipid dysregulation was linked to neurotransmitter dynamics. The potential neurotoxic effects further highlight the importance of understanding how steroid-specific mechanisms are linked to behavioral and neurobiological changes. This study advances our knowledge of the neurobiological effects, including the potential risks, of extended AAS use.\n                  <\/jats:p>","DOI":"10.1038\/s41386-026-02508-w","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:03:24Z","timestamp":1787745804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anabolic androgenic steroids induce distinct monoaminergic and lipidomic alterations in the male rat brain"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8216-5284","authenticated-orcid":false,"given":"Sofia","family":"Zelleroth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3345-5602","authenticated-orcid":false,"given":"Ibrahim","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frida","family":"Stam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Gising","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Larhed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Shariatgorji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9780-4168","authenticated-orcid":false,"given":"Alfhild","family":"Gr\u00f6nbladh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4062-7743","authenticated-orcid":false,"given":"Per E.","family":"Andr\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9835-870X","authenticated-orcid":false,"given":"Mathias","family":"Hallberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"2508_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.yhbeh.2009.09.006","volume":"58","author":"G Kanayama","year":"2010","unstructured":"Kanayama G, Hudson JI, Pope HG Jr. Illicit anabolic-androgenic steroid use. Horm Behav. 2010;58:111\u201321.","journal-title":"Horm Behav"},{"key":"2508_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mce.2017.02.039","volume":"464","author":"G Kanayama","year":"2018","unstructured":"Kanayama G, Pope HG. History and epidemiology of anabolic androgens in athletes and non-athletes. Mol Cell Endocrinol. 2018;464:4\u201313.","journal-title":"Mol Cell Endocrinol"},{"key":"2508_CR3","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1007\/s11469-019-00217-8","volume":"19","author":"E Hearne","year":"2021","unstructured":"Hearne E, Wazaify M, Van Hout MC, Atkinson A, McVeigh J. Anabolic-androgenic steroid use in the eastern mediterranean region: a scoping review of extant empirical literature. Int J Ment Health Addict. 2021;19:1162\u201389.","journal-title":"Int J Ment Health Addict"},{"key":"2508_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.peh.2018.11.001","volume":"6","author":"J Andreasson","year":"2019","unstructured":"Andreasson J, Henning A. Glocal fitness doping: policy, practice and prevention in the United States and Sweden. Perform Enhance Health. 2019;6:103\u201310.","journal-title":"Perform Enhance Health"},{"key":"2508_CR5","doi-asserted-by":"crossref","unstructured":"Norman C, Harries RL, Reid R, Nisbet LA, Nic Da\u00e9id N. Changing trends in anabolic-androgenic steroid use within Scottish prisons: Detection, prevalence, and quantitation. Drug Test Anal. 2024;17:858\u2013867.","DOI":"10.1002\/dta.3790"},{"key":"2508_CR6","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1111\/add.16643","volume":"119","author":"T Piatkowski","year":"2024","unstructured":"Piatkowski T, Whiteside B, Robertson J, Henning A, Lau EHY, Dunn M. What is the prevalence of anabolic-androgenic steroid use among women? A systematic review. Addiction. 2024;119:2088\u2013100.","journal-title":"Addiction"},{"key":"2508_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/MED.0000000000000403","volume":"25","author":"D Sagoe","year":"2018","unstructured":"Sagoe D, Pallesen S. Androgen abuse epidemiology. Curr Opin Endocrinol Diab Obes. 2018;25:185\u201394.","journal-title":"Curr Opin Endocrinol Diab Obes"},{"key":"2508_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108604","volume":"221","author":"LE Hauger","year":"2021","unstructured":"Hauger LE, Havnes IA, J\u00f8rstad ML, Bj\u00f8rnebekk A. Anabolic androgenic steroids, antisocial personality traits, aggression and violence. Drug Alcohol Depend. 2021;221:108604.","journal-title":"Drug Alcohol Depend"},{"key":"2508_CR9","doi-asserted-by":"crossref","unstructured":"Parkinson A, Evans N. Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc. 2006;38:644\u201351.","DOI":"10.1249\/01.mss.0000210194.56834.5d"},{"key":"2508_CR10","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1111\/j.1360-0443.2009.02734.x","volume":"104","author":"G Kanayama","year":"2009","unstructured":"Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG Jr. Anabolic-androgenic steroid dependence: an emerging disorder. Addiction. 2009;104:1966\u201378.","journal-title":"Addiction"},{"key":"2508_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000505978","volume":"89","author":"G Kanayama","year":"2020","unstructured":"Kanayama G, Hudson JI, Pope HG Jr. Anabolic-androgenic steroid use and body image in men: a growing concern for clinicians. Psychother Psychosom. 2020;89:65\u201373.","journal-title":"Psychother Psychosom"},{"key":"2508_CR12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1006\/hbeh.2001.1706","volume":"40","author":"ME Breuer","year":"2001","unstructured":"Breuer ME, McGinnis MY, Lumia AR, Possidente BP. Aggression in male rats receiving anabolic androgenic steroids: effects of social and environmental provocation. Horm Behav. 2001;40:409\u201318.","journal-title":"Horm Behav"},{"key":"2508_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.pbb.2015.05.001","volume":"134","author":"TR Morrison","year":"2015","unstructured":"Morrison TR, Ricci LA, Melloni RH Jr. Aggression and anxiety in adolescent AAS-treated hamsters: A role for 5HT3 receptors. Pharm Biochem Behav. 2015;134:85\u201391.","journal-title":"Pharm Biochem Behav"},{"key":"2508_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1001\/archpsyc.57.2.133","volume":"57","author":"HG Pope Jr","year":"2000","unstructured":"Pope HG Jr, Kouri EM, Hudson JI. Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. Arch Gen Psychiatry. 2000;57:133\u201340.","journal-title":"Arch Gen Psychiatry"},{"key":"2508_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-13048-w","volume":"12","author":"BS Nelson","year":"2022","unstructured":"Nelson BS, Hildebrandt T, Wallisch P. Anabolic\u2013androgenic steroid use is associated with psychopathy, risk-taking, anger, and physical problems. Sci Rep. 2022;12:9133.","journal-title":"Sci Rep"},{"key":"2508_CR16","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s00414-021-02587-y","volume":"135","author":"F Aknouche","year":"2021","unstructured":"Aknouche F, Gheddar L, Kernall\u00e9guen A, Maruejouls C, Kintz P. Anabolic steroids and extreme violence: a case of murder after chronic intake and under acute influence of metandienone and trenbolone. Int J Leg Med. 2021;135:1449\u201353.","journal-title":"Int J Leg Med"},{"key":"2508_CR17","first-page":"28","volume":"51","author":"HG Pope Jr","year":"1990","unstructured":"Pope HG Jr, Katz DL. Homicide and near-homicide by anabolic steroid users. J Clin Psychiatry. 1990;51:28\u201331.","journal-title":"J Clin Psychiatry"},{"key":"2508_CR18","doi-asserted-by":"crossref","unstructured":"B\u00f6rjesson A, M\u00f6ller C, Hagelin A, Vicente V, Rane A, Lehtihet M, et al. Male anabolic androgenic steroid users with personality disorders report more aggressive feelings, suicidal thoughts, and criminality. Medicina. 2020;56:265.","DOI":"10.3390\/medicina56060265"},{"key":"2508_CR19","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.jsams.2017.03.008","volume":"20","author":"AS Lindqvist Bagge","year":"2017","unstructured":"Lindqvist Bagge AS, Rosen T, Fahlke C, Ehrnborg C, Eriksson BO, Moberg T, et al. Somatic effects of AAS abuse: a 30-year follow-up study of male former power sports athletes. J Sci Med Sport. 2017;20:814\u201318.","journal-title":"J Sci Med Sport"},{"key":"2508_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fnins.2019.00172","volume":"13","author":"J Joksimovic","year":"2019","unstructured":"Joksimovic J, Selakovic D, Jovicic N, Mitrovic S, Mihailovic V, Katanic J, et al. Exercise attenuates anabolic steroids-induced anxiety via hippocampal NPY and MC4 receptor in rats. Front Neurosci. 2019;13:172.","journal-title":"Front Neurosci"},{"key":"2508_CR21","first-page":"703","volume":"35","author":"G Rosic","year":"2014","unstructured":"Rosic G, Joksimovic J, Selakovic D, Milovanovic D, Jakovljevic V. Anxiogenic effects of chronic exposure to nandrolone decanoate (ND) at supraphysiological dose in rats: a brief report. Neuro Endocrinol Lett. 2014;35:703\u201310.","journal-title":"Neuro Endocrinol Lett"},{"key":"2508_CR22","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.jns.2017.08.2179","volume":"381","author":"H Pope","year":"2017","unstructured":"Pope H, Kanayama G, Jane\u2019s A, Hudson J, Brennan B, Jensen E, et al. Long-term anabolic-androgenic steroid (AAS) use: a possible new risk factor for early dementia. J Neurological Sci. 2017;381:772.","journal-title":"J Neurological Sci"},{"key":"2508_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2008.05.004","volume":"98","author":"G Kanayama","year":"2008","unstructured":"Kanayama G, Hudson JI, Pope HG Jr. Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug Alcohol Depend. 2008;98:1\u201312.","journal-title":"Drug Alcohol Depend"},{"key":"2508_CR24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.drugalcdep.2012.11.008","volume":"130","author":"G Kanayama","year":"2013","unstructured":"Kanayama G, Kean J, Hudson JI, Pope HG Jr. Cognitive deficits in long-term anabolic-androgenic steroid users. Drug Alcohol Depend. 2013;130:208\u201314.","journal-title":"Drug Alcohol Depend"},{"key":"2508_CR25","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/j.1875-9114.2012.01123","volume":"32","author":"EJ Ip","year":"2012","unstructured":"Ip EJ, Lu DH, Barnett MJ, Tenerowicz MJ, Vo JC, Perry PJ. Psychological and physical impact of anabolic-androgenic steroid dependence. Pharmacotherapy. 2012;32:910\u20139.","journal-title":"Pharmacotherapy"},{"key":"2508_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.neubiorev.2019.02.014","volume":"100","author":"MJ Kaufman","year":"2019","unstructured":"Kaufman MJ, Kanayama G, Hudson JI, Pope HG. Supraphysiologic-dose anabolic\u2013androgenic steroid use: a risk factor for dementia? Neurosci Biobehav Rev. 2019;100:180\u2013207.","journal-title":"Neurosci Biobehav Rev"},{"key":"2508_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fncel.2013.00069","volume":"7","author":"JR Basile","year":"2013","unstructured":"Basile JR, Binmadi NO, Zhou H, Yang YH, Paoli A, Proia P. Supraphysiological doses of performance-enhancing anabolic-androgenic steroids exert direct toxic effects on neuron-like cells. Front Cell Neurosci. 2013;7:69.","journal-title":"Front Cell Neurosci"},{"key":"2508_CR28","doi-asserted-by":"publisher","first-page":"25492","DOI":"10.1074\/jbc.M603193200","volume":"281","author":"M Estrada","year":"2006","unstructured":"Estrada M, Varshney A, Ehrlich BE. Elevated testosterone induces apoptosis in neuronal cells. J Biol Chem. 2006;281:25492\u2013501.","journal-title":"J Biol Chem"},{"key":"2508_CR29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.neuroscience.2018.11.035","volume":"397","author":"S Zelleroth","year":"2019","unstructured":"Zelleroth S, Nylander E, Nyberg F, Gronbladh A, Hallberg M. Toxic impact of anabolic androgenic steroids in primary rat cortical cell cultures. Neuroscience. 2019;397:172\u201383.","journal-title":"Neuroscience"},{"key":"2508_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2021.105863","volume":"210","author":"S Zelleroth","year":"2021","unstructured":"Zelleroth S, Nylander E, \u00d6rtenblad A, Stam F, Nyberg F, Gr\u00f6nbladh A, et al. Structurally different anabolic androgenic steroids reduce neurite outgrowth and neuronal viability in primary rat cortical cell cultures. J Steroid Biochem Mol Biol. 2021;210:105863.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2508_CR31","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.biopsych.2016.06.017","volume":"82","author":"A Bjornebekk","year":"2017","unstructured":"Bjornebekk A, Walhovd KB, Jorstad ML, Due-Tonnessen P, Hullstein IR, Fjell AM. Structural brain imaging of long-term anabolic-androgenic steroid users and nonusing weightlifters. Biol Psychiatry. 2017;82:294\u2013302.","journal-title":"Biol Psychiatry"},{"key":"2508_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.drugalcdep.2015.04.023","volume":"152","author":"MJ Kaufman","year":"2015","unstructured":"Kaufman MJ, Janes AC, Hudson JI, Brennan BP, Kanayama G, Kerrigan AR, et al. Brain and cognition abnormalities in long-term anabolic-androgenic steroid users. Drug Alcohol Depend. 2015;152:47\u201356.","journal-title":"Drug Alcohol Depend"},{"key":"2508_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.nicl.2016.11.014","volume":"13","author":"LT Westlye","year":"2017","unstructured":"Westlye LT, Kaufmann T, Alnaes D, Hullstein IR, Bjornebekk A. Brain connectivity aberrations in anabolic-androgenic steroid users. Neuroimage Clin. 2017;13:62\u201369.","journal-title":"Neuroimage Clin"},{"key":"2508_CR34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.brainres.2008.05.014","volume":"1219","author":"C Birgner","year":"2008","unstructured":"Birgner C, Kindlundh-H\u00f6gberg AM, Oreland L, Alsi\u00f6 J, Lindblom J, Schi\u00f6th HB, et al. Reduced activity of monoamine oxidase in the rat brain following repeated nandrolone decanoate administration. Brain Res. 2008;1219:103\u201310.","journal-title":"Brain Res"},{"key":"2508_CR35","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0278-5846(02)00293-2","volume":"26","author":"AM Kindlundh","year":"2002","unstructured":"Kindlundh AM, Bergstrom M, Monazzam A, Hallberg M, Blomqvist G, Langstrom B, et al. Dopaminergic effects after chronic treatment with nandrolone visualized in rat brain by positron emission tomography. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:1303\u20138.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2508_CR36","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1046\/j.0953-816X.2000.01402.x","volume":"13","author":"AM Kindlundh","year":"2001","unstructured":"Kindlundh AM, Lindblom J, Bergstr\u00f6m L, Wikberg JE, Nyberg F. The anabolic-androgenic steroid nandrolone decanoate affects the density of dopamine receptors in the male rat brain. Eur J Neurosci. 2001;13:291\u20136.","journal-title":"Eur J Neurosci"},{"key":"2508_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neulet.2003.11.040","volume":"356","author":"AM Kindlundh","year":"2004","unstructured":"Kindlundh AM, Rahman S, Lindblom J, Nyberg F. Increased dopamine transporter density in the male rat brain following chronic nandrolone decanoate administration. Neurosci Lett. 2004;356:131\u20134.","journal-title":"Neurosci Lett"},{"key":"2508_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0166-4328(01)00408-9","volume":"133","author":"A-S Lindqvist","year":"2002","unstructured":"Lindqvist A-S, Johansson-Steensland P, Nyberg F, Fahlke C. Anabolic androgenic steroid affects competitive behaviour, behavioural response to ethanol and brain serotonin levels. Behavioural Brain Res. 2002;133:21\u201329.","journal-title":"Behavioural Brain Res"},{"key":"2508_CR39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ghir.2014.01.002","volume":"24","author":"A Gronbladh","year":"2014","unstructured":"Gronbladh A, Johansson J, Nyberg F, Hallberg M. Administration of growth hormone and nandrolone decanoate alters mRNA expression of the GABAB receptor subunits as well as of the GH receptor, IGF-1, and IGF-2 in rat brain. Growth Horm IGF Res. 2014;24:60\u20136.","journal-title":"Growth Horm IGF Res"},{"key":"2508_CR40","doi-asserted-by":"crossref","unstructured":"Teleanu RI, Niculescu AG, Roza E, Vlad\u00e2cenco O, Grumezescu AM, Teleanu DM. Neurotransmitters are key factors in neurological and neurodegenerative disorders of the central nervous system. Int J Mol Sci. 2022;23:5954.","DOI":"10.3390\/ijms23115954"},{"key":"2508_CR41","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1007\/s12035-019-01775-7","volume":"57","author":"PA Postila","year":"2020","unstructured":"Postila PA, R\u00f3g T. A perspective: active role of lipids in neurotransmitter dynamics. Mol Neurobiol. 2020;57:910\u201325.","journal-title":"Mol Neurobiol"},{"key":"2508_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adc9317","volume":"8","author":"JH Yoon","year":"2022","unstructured":"Yoon JH, Seo Y, Jo YS, Lee S, Cho E, Cazenave-Gassiot A, et al. Brain lipidomics: From functional landscape to clinical significance. Sci Adv. 2022;8:eadc9317.","journal-title":"Sci Adv"},{"key":"2508_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48734-y","volume":"15","author":"M Osetrova","year":"2024","unstructured":"Osetrova M, Tkachev A, Mair W, Guijarro Larraz P, Efimova O, Kurochkin I, et al. Lipidome atlas of the adult human brain. Nat Commun. 2024;15:4455.","journal-title":"Nat Commun"},{"key":"2508_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yclnex.2018.05.001","volume":"20","author":"A Shamim","year":"2018","unstructured":"Shamim A, Mahmood T, Ahsan F, Kumar A, Bagga P. Lipids: an insight into the neurodegenerative disorders. Clin Nutr Exp. 2018;20:1\u201319.","journal-title":"Clin Nutr Exp"},{"key":"2508_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2021.100899","volume":"61","author":"DB Castellanos","year":"2021","unstructured":"Castellanos DB, Mart\u00edn-Jim\u00e9nez CA, Rojas-Rodr\u00edguez F, Barreto GE, Gonz\u00e1lez J. Brain lipidomics as a rising field in neurodegenerative contexts: perspectives with machine learning approaches. Front Neuroendocrinol. 2021;61:100899.","journal-title":"Front Neuroendocrinol"},{"key":"2508_CR46","doi-asserted-by":"publisher","first-page":"176","DOI":"10.21926\/obm.geriatr.2103176","volume":"05","author":"X Quan","year":"2021","unstructured":"Quan X, Bakovic M. Regulation of membrane phospholipid homeostasis in neurodegenerative diseases. OBM Geriatrics. 2021;05:176.","journal-title":"OBM Geriatrics"},{"key":"2508_CR47","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.steroids.2011.12.014","volume":"77","author":"P Tucci","year":"2012","unstructured":"Tucci P, Morgese MG, Colaianna M, Zotti M, Schiavone S, Cuomo V, et al. Neurochemical consequence of steroid abuse: stanozolol-induced monoaminergic changes. Steroids. 2012;77:269\u201375.","journal-title":"Steroids"},{"key":"2508_CR48","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/sj.bjp.0702412","volume":"126","author":"I Thiblin","year":"1999","unstructured":"Thiblin I, Finn A, Ross SB, Stenfors C. Increased dopaminergic and 5-hydroxytryptaminergic activities in male rat brain following long-term treatment with anabolic androgenic steroids. Br J Pharm. 1999;126:1301\u20136.","journal-title":"Br J Pharm"},{"key":"2508_CR49","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/FBP.0b013e32833b10f1","volume":"21","author":"JJ Schwartzer","year":"2010","unstructured":"Schwartzer JJ, Melloni RH. Anterior hypothalamic dopamine D2 receptors modulate adolescent anabolic\/androgenic steroid-induced offensive aggression in the Syrian hamster. Behavioural Pharmacol. 2010;21:314\u201322.","journal-title":"Behavioural Pharmacol"},{"key":"2508_CR50","doi-asserted-by":"crossref","unstructured":"Morrison TR, Ricci LA, Puckett AS, Joyce J, Curran R, Davis C, et al. Serotonin type-3 receptors differentially modulate anxiety and aggression during withdrawal from adolescent anabolic steroid exposure. Hormones Behavior. 2020;119:104650.","DOI":"10.1016\/j.yhbeh.2019.104650"},{"key":"2508_CR51","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.yhbeh.2012.09.007","volume":"62","author":"LA Ricci","year":"2012","unstructured":"Ricci LA, Morrison TR, Melloni RH Jr. Serotonin modulates anxiety-like behaviors during withdrawal from adolescent anabolic-androgenic steroid exposure in Syrian hamsters. Horm Behav. 2012;62:569\u201378.","journal-title":"Horm Behav"},{"key":"2508_CR52","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00213-017-4810-7","volume":"235","author":"KG Wallin-Miller","year":"2018","unstructured":"Wallin-Miller KG, Kreutz F, Li G, Wood RI. Anabolic-androgenic steroids (AAS) increase sensitivity to uncertainty by inhibition of dopamine D1 and D2 receptors. Psychopharmacology. 2018;235:959\u201369.","journal-title":"Psychopharmacology"},{"key":"2508_CR53","doi-asserted-by":"crossref","unstructured":"Dhar R, Stout CW, Link MS, Homoud MK, Weinstock J, Estes III NM. Cardiovascular toxicities of performance-enhancing substances in sports. Mayo Clinic Proceedings. 2005;80:1307\u20131315.","DOI":"10.4065\/80.10.1307"},{"key":"2508_CR54","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1249\/JSR.0000000000000467","volume":"17","author":"MW Niedfeldt","year":"2018","unstructured":"Niedfeldt MW. Anabolic steroid effects on the liver. Curr Sports Med Rep. 2018;17:97\u2013102.","journal-title":"Curr Sports Med Rep"},{"key":"2508_CR55","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-019-1632-0","volume":"16","author":"D Balgoma","year":"2020","unstructured":"Balgoma D, Zelleroth S, Gr\u00f6nbladh A, Hallberg M, Pettersson C, Hedeland M. Anabolic androgenic steroids exert a selective remodeling of the plasma lipidome that mirrors the decrease of the de novo lipogenesis in the liver. Metabolomics. 2020;16:12.","journal-title":"Metabolomics"},{"key":"2508_CR56","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/npp.2013.215","volume":"39","author":"M Shariatgorji","year":"2014","unstructured":"Shariatgorji M, Svenningsson P, Andren PE. Mass spectrometry imaging, an emerging technology in neuropsychopharmacology. Neuropsychopharmacology. 2014;39:34\u201349.","journal-title":"Neuropsychopharmacology"},{"key":"2508_CR57","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1021\/cr3004295","volume":"113","author":"JL Norris","year":"2013","unstructured":"Norris JL, Caprioli RM. Analysis of tissue specimens by matrix-assisted laser desorption\/ionization imaging mass spectrometry in biological and clinical research. Chem Rev. 2013;113:2309\u201342.","journal-title":"Chem Rev"},{"key":"2508_CR58","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/mas.20124","volume":"26","author":"LA McDonnell","year":"2007","unstructured":"McDonnell LA, Heeren RMA. Imaging mass spectrometry. Mass Spectrom Rev. 2007;26:606\u201343.","journal-title":"Mass Spectrom Rev"},{"key":"2508_CR59","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1021\/acschembio.1c00803","volume":"17","author":"E Fridjonsdottir","year":"2022","unstructured":"Fridjonsdottir E, Vallianatou T, Mantas I, Shariatgorji R, Nilsson A, Schembri LS, et al. Region-specific and age-dependent multitarget effects of acetylcholinesterase inhibitor tacrine on comprehensive neurotransmitter systems. Acs Chem Biol. 2022;17:147\u201358.","journal-title":"Acs Chem Biol"},{"key":"2508_CR60","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/s41592-019-0551-3","volume":"16","author":"M Shariatgorji","year":"2019","unstructured":"Shariatgorji M, Nilsson A, Fridjonsdottir E, Vallianatou T, Kallback P, Katan L, et al. Comprehensive mapping of neurotransmitter networks by MALDI-MS imaging. Nat Methods. 2019;16:1021.","journal-title":"Nat Methods"},{"key":"2508_CR61","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1021\/acschemneuro.1c00103","volume":"12","author":"T Vallianatou","year":"2021","unstructured":"Vallianatou T, Shariatgorji R, Nilsson A, Karlgren M, Hulme H, Fridjonsdottir E, et al. Integration of mass spectrometry imaging and machine learning visualizes region-specific age-induced and drug-target metabolic perturbations in the brain. Acs Chem Neurosci. 2021;12:1811\u201323.","journal-title":"Acs Chem Neurosci"},{"key":"2508_CR62","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41531-023-00558-1","volume":"9","author":"I Kaya","year":"2023","unstructured":"Kaya I, Nilsson A, Lupt\u00e1kov\u00e1 D, He Y, Vallianatou T, Bj\u00e4rterot P, et al. Spatial lipidomics reveals brain region-specific changes of sulfatides in an experimental MPTP Parkinson\u2019s disease primate model. npj Parkinson\u2019s Dis. 2023;9:118.","journal-title":"npj Parkinson\u2019s Dis"},{"key":"2508_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.yhbeh.2024.105501","volume":"161","author":"S Zelleroth","year":"2024","unstructured":"Zelleroth S, Stam F, Nylander E, Kjellgren E, Gising J, Larhed M, et al. The decanoate esters of nandrolone, testosterone, and trenbolone induce steroid-specific memory impairment and somatic effects in the male rat. Horm Behav. 2024;161:105501.","journal-title":"Horm Behav"},{"key":"2508_CR64","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.yhbeh.2015.07.007","volume":"73","author":"MAE Ahmed","year":"2015","unstructured":"Ahmed MAE, El-Awdan SA. Lipoic acid and pentoxifylline mitigate nandrolone decanoate-induced neurobehavioral perturbations in rats via rebalance of brain neurotransmitters, up-regulation of Nrf2\/HO-1 pathway, and down-regulation of TNFR1 expression. Hormones Behav. 2015;73:186\u201399.","journal-title":"Hormones Behav"},{"key":"2508_CR65","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neuro.2019.11.001","volume":"76","author":"ME El-Shamarka","year":"2020","unstructured":"El-Shamarka ME, Sayed RH, Assaf N, Zeidan HM, Hashish AF. Combined neurotoxic effects of cannabis and nandrolone decanoate in adolescent male rats. Neurotoxicology. 2020;76:114\u201325.","journal-title":"Neurotoxicology"},{"key":"2508_CR66","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1530\/JOE-12-0315","volume":"216","author":"A Gronbladh","year":"2013","unstructured":"Gronbladh A, Johansson J, Nostl A, Nyberg F, Hallberg M. GH improves spatial memory and reverses certain anabolic androgenic steroid-induced effects in intact rats. J Endocrinol. 2013;216:31\u201341.","journal-title":"J Endocrinol"},{"key":"2508_CR67","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neulet.2009.09.041","volume":"467","author":"K Magnusson","year":"2009","unstructured":"Magnusson K, Hanell A, Bazov I, Clausen F, Zhou Q, Nyberg F. Nandrolone decanoate administration elevates hippocampal prodynorphin mRNA expression and impairs Morris water maze performance in male rats. Neurosci Lett. 2009;467:189\u201393.","journal-title":"Neurosci Lett"},{"key":"2508_CR68","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.steroids.2004.11.010","volume":"70","author":"P Steensland","year":"2005","unstructured":"Steensland P, Hallberg M, Kindlundh A, Fahlke C, Nyberg F. Amphetamine-induced aggression is enhanced in rats pre-treated with the anabolic androgenic steroid nandrolone decanoate. Steroids. 2005;70:199\u2013204.","journal-title":"Steroids"},{"key":"2508_CR69","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.yhbeh.2012.10.003","volume":"63","author":"F Tanehkar","year":"2013","unstructured":"Tanehkar F, Rashidy-Pour A, Vafaei AA, Sameni HR, Haghighi S, Miladi-Gorji H, et al. Voluntary exercise does not ameliorate spatial learning and memory deficits induced by chronic administration of nandrolone decanoate in rats. Horm Behav. 2013;63:158\u201365.","journal-title":"Horm Behav"},{"key":"2508_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2022.113971","volume":"432","author":"S Zelleroth","year":"2022","unstructured":"Zelleroth S, Nylander E, Kjellgren E, Gr\u00f6nbladh A, Hallberg M. Nandrolone decanoate and testosterone undecanoate differently affect stress hormones, neurotransmitter systems, and general activity in the male rat. Behavioural Brain Res. 2022;432:113971.","journal-title":"Behavioural Brain Res"},{"key":"2508_CR71","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1038\/s41596-021-00538-w","volume":"16","author":"R Shariatgorji","year":"2021","unstructured":"Shariatgorji R, Nilsson A, Fridjonsdottir E, Strittmatter N, Dannhorn A, Svenningsson P, et al. Spatial visualization of comprehensive brain neurotransmitter systems and neuroactive substances by selective in situ chemical derivatization mass spectrometry imaging. Nat Protoc. 2021;16:3298\u2013321.","journal-title":"Nat Protoc"},{"key":"2508_CR72","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00216-011-4929-z","volume":"401","author":"SO Deininger","year":"2011","unstructured":"Deininger SO, Cornett DS, Paape R, Becker M, Pineau C, Rauser S, et al. Normalization in MALDI-TOF imaging datasets of proteins: practical considerations. Anal Bioanal Chem. 2011;401:167\u201381.","journal-title":"Anal Bioanal Chem"},{"key":"2508_CR73","doi-asserted-by":"publisher","first-page":"4941","DOI":"10.1016\/j.jprot.2012.07.034","volume":"75","author":"P Kallback","year":"2012","unstructured":"Kallback P, Shariatgorji M, Nilsson A, Andren PE. Novel mass spectrometry imaging software assisting labeled normalization and quantitation of drugs and neuropeptides directly in tissue sections. J Proteom. 2012;75:4941\u201351.","journal-title":"J Proteom"},{"key":"2508_CR74","unstructured":"Paxinos G, Watson C. Paxinos\u2019s and Watson\u2019s The rat brain in stereotaxic coordinates. Seventh edition. Elsevier\/AP, Academic Press: Amsterdam; 2014"},{"key":"2508_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41539-5","volume":"14","author":"Y He","year":"2023","unstructured":"He Y, Kaya I, Shariatgorji R, Lundkvist J, Wahlberg LU, Nilsson A, et al. Prosaposin maintains lipid homeostasis in dopamine neurons and counteracts experimental Parkinsonism in rodents. Nat Commun. 2023;14:5804.","journal-title":"Nat Commun"},{"key":"2508_CR76","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41531-025-01109-6","volume":"11","author":"I Kaya","year":"2025","unstructured":"Kaya I, Vallianatou T, Nilsson A, Bj\u00e4rterot P, Shariatgorji R, Svenningsson P, et al. Brain-region-specific lipid dysregulation in L-DOPA-induced dyskinesia in a primate model of Parkinson\u2019s disease. npj Parkinson\u2019s Dis. 2025;11:258.","journal-title":"npj Parkinson\u2019s Dis"},{"key":"2508_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2026.107372","volume":"223","author":"Y He","year":"2026","unstructured":"He Y, Kaya I, Zhang X, Nilsson A, Cao L, Andren PE, et al. Spatial lipidomics identifies \u03b1-synuclein-induced lipid changes in an AAV-induced Parkinsonian mouse model. Neurobiol Dis. 2026;223:107372.","journal-title":"Neurobiol Dis"},{"key":"2508_CR78","doi-asserted-by":"publisher","first-page":"D1677","DOI":"10.1093\/nar\/gkad896","volume":"52","author":"MJ Conroy","year":"2024","unstructured":"Conroy MJ, Andrews RM, Andrews S, Cockayne L, Dennis EA, Fahy E, et al. LIPID MAPS: update to databases and tools for the lipidomics community. Nucleic Acids Res. 2024;52:D1677\u2013D82.","journal-title":"Nucleic Acids Res"},{"key":"2508_CR79","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0197-0186(85)90108-1","volume":"7","author":"BHC Westerink","year":"1985","unstructured":"Westerink BHC. Sequence and significance of dopamine metabolism in the rat brain. Neurochem Int. 1985;7:221\u201327.","journal-title":"Neurochem Int"},{"key":"2508_CR80","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.tins.2020.10.016","volume":"44","author":"E Valjent","year":"2021","unstructured":"Valjent E, Gangarossa G. The tail of the striatum: from anatomy to connectivity and function. Trends Neurosci. 2021;44:203\u201314.","journal-title":"Trends Neurosci"},{"key":"2508_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.cobeha.2024.101441","volume":"59","author":"I Green","year":"2024","unstructured":"Green I, Amo R, Watabe-Uchida M. Shifting attention to orient or avoid: a unifying account of the tail of the striatum and its dopaminergic inputs. Curr Opin Behav Sci. 2024;59:101441.","journal-title":"Curr Opin Behav Sci"},{"key":"2508_CR82","doi-asserted-by":"publisher","first-page":"461","DOI":"10.14348\/molcells.2023.0051","volume":"46","author":"K Lee","year":"2023","unstructured":"Lee K, An SY, Park J, Lee S, Kim HF. Anatomical and functional comparison of the caudate tail in primates and the tail of the striatum in rodents: implications for sensory information processing and habitual behavior. Mol Cells. 2023;46:461\u201369.","journal-title":"Mol Cells"},{"key":"2508_CR83","doi-asserted-by":"crossref","unstructured":"Jiang H, Kim HF. Anatomical inputs from the sensory and value structures to the tail of the rat striatum. Front Neuroanat. 2018;12:30.","DOI":"10.3389\/fnana.2018.00030"},{"key":"2508_CR84","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.cell.2015.10.063","volume":"163","author":"HF Kim","year":"2015","unstructured":"Kim HF, Ghazizadeh A, Hikosaka O. Dopamine neurons encoding long-term memory of object value for habitual behavior. Cell. 2015;163:1165\u201375.","journal-title":"Cell"},{"key":"2508_CR85","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/s41593-018-0222-1","volume":"21","author":"W Menegas","year":"2018","unstructured":"Menegas W, Akiti K, Amo R, Uchida N, Watabe-Uchida M. Dopamine neurons projecting to the posterior striatum reinforce avoidance of threatening stimuli. Nat Neurosci. 2018;21:1421\u201330.","journal-title":"Nat Neurosci"},{"key":"2508_CR86","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.21886","volume":"6","author":"W Menegas","year":"2017","unstructured":"Menegas W, Babayan BM, Uchida N, Watabe-Uchida M. Opposite initialization to novel cues in dopamine signaling in ventral and posterior striatum in mice. eLife. 2017;6:e21886.","journal-title":"eLife"},{"key":"2508_CR87","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.psyneuen.2015.03.023","volume":"57","author":"KG Wallin","year":"2015","unstructured":"Wallin KG, Alves JM, Wood RI. Anabolic-androgenic steroids and decision making: Probability and effort discounting in male rats. Psychoneuroendocrinology. 2015;57:84\u201392.","journal-title":"Psychoneuroendocrinology"},{"key":"2508_CR88","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.euroneuro.2015.01.002","volume":"25","author":"KG Wallin","year":"2015","unstructured":"Wallin KG, Wood RI. Anabolic\u2013androgenic steroids impair set-shifting and reversal learning in male rats. Eur Neuropsychopharmacol. 2015;25:583\u201390.","journal-title":"Eur Neuropsychopharmacol"},{"key":"2508_CR89","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.biopsych.2005.11.015","volume":"59","author":"EJ Hermans","year":"2006","unstructured":"Hermans EJ, Putman P, Baas JM, Koppeschaar HP, van Honk J. A single administration of testosterone reduces fear-potentiated startle in humans. Biol Psychiatry. 2006;59:872\u201374.","journal-title":"Biol Psychiatry"},{"key":"2508_CR90","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.biopsych.2005.04.003","volume":"58","author":"J van Honk","year":"2005","unstructured":"van Honk J, Peper JS, Schutter DJLG. Testosterone reduces unconscious fear but not consciously experienced anxiety: implications for the disorders of fear and anxiety. Biol Psychiatry. 2005;58:218\u201325.","journal-title":"Biol Psychiatry"},{"key":"2508_CR91","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1007\/s00213-019-05239-7","volume":"236","author":"LE Hauger","year":"2019","unstructured":"Hauger LE, Sagoe D, Vaskinn A, Arnevik EA, Leknes S, J\u00f8rstad ML, et al. Anabolic androgenic steroid dependence is associated with impaired emotion recognition. Psychopharmacol (Berl). 2019;236:2667\u201376.","journal-title":"Psychopharmacol (Berl)"},{"key":"2508_CR92","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00213-023-06497-2","volume":"241","author":"M Scarth","year":"2024","unstructured":"Scarth M, Hauger LE, Thorsby PM, Leknes S, Hullstein IR, Westlye LT, et al. Supraphysiological testosterone levels from anabolic steroid use and reduced sensitivity to negative facial expressions in men. Psychopharmacology. 2024;241:701\u201315.","journal-title":"Psychopharmacology"},{"key":"2508_CR93","doi-asserted-by":"crossref","unstructured":"Occurrence and Importance of Ether Lipids in the Brain. In: Farooqui AA, Farooqui T, Horrocks LA, editors. Metabolism and functions of bioactive ether lipids in the brain. New York: Springer New York; 2008. pp. 1\u201316.","DOI":"10.1007\/978-0-387-77401-5_1"},{"key":"2508_CR94","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1002\/1873-3468.14992","volume":"598","author":"M Santos","year":"2024","unstructured":"Santos M, Melo T, Maur\u00edcio T, Ferreira H, Domingues P, Domingues R. The non-enzymatic oxidation of phosphatidylethanolamine and phosphatidylserine and their intriguing roles in inflammation dynamics and diseases. FEBS Lett. 2024;598:2174\u201389.","journal-title":"FEBS Lett"},{"key":"2508_CR95","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1194\/jlr.R084004","volume":"59","author":"JE Vance","year":"2018","unstructured":"Vance JE. Historical perspective: phosphatidylserine and phosphatidylethanolamine from the 1800s to the present. J Lipid Res. 2018;59:923\u201344.","journal-title":"J Lipid Res"},{"key":"2508_CR96","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.bbalip.2012.08.016","volume":"1831","author":"JE Vance","year":"2013","unstructured":"Vance JE, Tasseva G. Formation and function of phosphatidylserine and phosphatidylethanolamine in mammalian cells. Biochim Biophys Acta. 2013;1831:543\u201354.","journal-title":"Biochim Biophys Acta"},{"key":"2508_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.975176","volume":"14","author":"X Ma","year":"2022","unstructured":"Ma X, Li X, Wang W, Zhang M, Yang B, Miao Z. Phosphatidylserine, inflammation, and central nervous system diseases. Front Aging Neurosci. 2022;14:975176.","journal-title":"Front Aging Neurosci"},{"key":"2508_CR98","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1177\/1073858409337035","volume":"15","author":"AA Farooqui","year":"2009","unstructured":"Farooqui AA. Lipid mediators in the neural cell nucleus: their metabolism, signaling, and association with neurological disorders. Neuroscientist. 2009;15:392\u2013407.","journal-title":"Neuroscientist"},{"key":"2508_CR99","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.tcb.2013.05.002","volume":"23","author":"D Puchkov","year":"2013","unstructured":"Puchkov D, Haucke V. Greasing the synaptic vesicle cycle by membrane lipids. Trends Cell Biol. 2013;23:493\u2013503.","journal-title":"Trends Cell Biol"},{"key":"2508_CR100","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuron.2016.02.033","volume":"90","author":"E Lauwers","year":"2016","unstructured":"Lauwers E, Goodchild R, Verstreken P. Membrane lipids in presynaptic function and disease. Neuron. 2016;90:11\u201325.","journal-title":"Neuron"},{"key":"2508_CR101","first-page":"2017","volume":"ume 10","author":"Z Yang","year":"2017","unstructured":"Yang Z, Gou L, Chen S, Li N, Zhang S, Zhang L. Membrane fusion involved in neurotransmission: glimpse from electron microscope and molecular simulation. Front Mol Neurosci. 2017;ume 10:2017.","journal-title":"Front Mol Neurosci"},{"key":"2508_CR102","doi-asserted-by":"crossref","unstructured":"Tracey TJ, Steyn FJ, Wolvetang EJ, Ngo ST. Neuronal lipid metabolism: multiple pathways driving functional outcomes in health and disease. Front Mol Neurosci. 2018;11:10.","DOI":"10.3389\/fnmol.2018.00010"},{"key":"2508_CR103","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s40478-022-01469-7","volume":"10","author":"Y Fu","year":"2022","unstructured":"Fu Y, He Y, Phan K, Bhatia S, Pickford R, Wu P, et al. Increased unsaturated lipids underlie lipid peroxidation in the synucleinopathy brain. Acta Neuropathol Commun. 2022;10:165.","journal-title":"Acta Neuropathol Commun"},{"key":"2508_CR104","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cotox.2020.08.002","volume":"20-21","author":"OV Oskolkova","year":"2020","unstructured":"Oskolkova OV, Bochkov VN. Gain-of-function mechanisms triggering biological effects of oxidized phospholipids. Curr Opin Toxicol. 2020;20-21:85\u201394.","journal-title":"Curr Opin Toxicol"},{"key":"2508_CR105","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.freeradbiomed.2011.06.027","volume":"51","author":"TT Reed","year":"2011","unstructured":"Reed TT. Lipid peroxidation and neurodegenerative disease. Free Radic Biol Med. 2011;51:1302\u201319.","journal-title":"Free Radic Biol Med"},{"key":"2508_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60457-w","volume":"10","author":"K Phan","year":"2020","unstructured":"Phan K, He Y, Pickford R, Bhatia S, Katzeff JS, Hodges JR, et al. Uncovering pathophysiological changes in frontotemporal dementia using serum lipids. Sci Rep. 2020;10:3640.","journal-title":"Sci Rep"},{"key":"2508_CR107","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.363","volume":"4","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Liu Y, Sun J, Zhang W, Guo Z, Ma Q. Arachidonic acid metabolism in health and disease. MedComm. 2023;4:e363.","journal-title":"MedComm"},{"key":"2508_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2026.106938","volume":"258","author":"HS Nascimento","year":"2026","unstructured":"Nascimento HS, Corr\u00eaa MG, Lemos OL, Lima HN, Amaral. LSdB. Anabolic-androgenic steroids at supraphysiological doses: Cardiovascular impacts and pathophysiological mechanisms. J Steroid Biochem Mol Biol. 2026;258:106938.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2508_CR109","doi-asserted-by":"crossref","unstructured":"Simankowicz P, St\u0119pniewska J. The role of endocannabinoids in physiological processes and disease pathology: a comprehensive review. J Clin Med. 2025;14:2851.","DOI":"10.3390\/jcm14082851"},{"key":"2508_CR110","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41401-018-0075-x","volume":"40","author":"M Scherma","year":"2019","unstructured":"Scherma M, Masia P, Satta V, Fratta W, Fadda P, Tanda G. Brain activity of anandamide: a rewarding bliss? Acta Pharm Sin. 2019;40:309\u201323.","journal-title":"Acta Pharm Sin"},{"key":"2508_CR111","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1097\/MED.0000000000000675","volume":"28","author":"M Scarth","year":"2021","unstructured":"Scarth M, Bj\u00f8rnebekk A. Androgen abuse and the brain. Curr Opin Endocrinol, Diab Obes. 2021;28:604\u201314.","journal-title":"Curr Opin Endocrinol, Diab Obes"},{"key":"2508_CR112","doi-asserted-by":"crossref","unstructured":"Underwood M. Taking \u2018the God of all Steroids\u2019 and \u2018Making a Pact With the Devil\u2019: online bodybuilding communities and the negotiation of trenbolone risk. In: Henning A, Andreasson J, editors. Doping in sport and fitness. Bingley, United Kingdom: Emerald Publishing Limited; 2022. p. 111\u201336.","DOI":"10.1108\/S1476-285420220000016007"},{"key":"2508_CR113","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/dar.13656","volume":"42","author":"TM Piatkowski","year":"2023","unstructured":"Piatkowski TM, Neumann DL, Dunn M. My mind pretty much went to mush\u2019: A qualitative exploration of trenbolone in the performance and image-enhancing drug community. Drug Alcohol Rev. 2023;42:1566\u201376.","journal-title":"Drug Alcohol Rev"},{"key":"2508_CR114","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.taap.2014.11.007","volume":"282","author":"F Ma","year":"2015","unstructured":"Ma F, Liu D. 17beta-trenbolone, an anabolic-androgenic steroid as well as an environmental hormone, contributes to neurodegeneration. Toxicol Appl Pharm. 2015;282:68\u201376.","journal-title":"Toxicol Appl Pharm"},{"key":"2508_CR115","doi-asserted-by":"publisher","first-page":"114647","DOI":"10.1016\/j.biopha.2023.114647","volume":"162","author":"J Song","year":"2023","unstructured":"Song J. Amygdala activity and amygdala-hippocampus connectivity: metabolic diseases, dementia, and neuropsychiatric issues. Biomed Pharmacother. 2023;162:114647.","journal-title":"Biomed Pharmacother"},{"key":"2508_CR116","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.yhbeh.2013.10.002","volume":"64","author":"LA Ricci","year":"2013","unstructured":"Ricci LA, Morrison TR, Melloni RH Jr. Adolescent anabolic\/androgenic steroids: Aggression and anxiety during exposure predict behavioral responding during withdrawal in Syrian hamsters (Mesocricetus auratus). Horm Behav. 2013;64:770\u201380.","journal-title":"Horm Behav"},{"key":"2508_CR117","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nrn2174","volume":"8","author":"RJ Nelson","year":"2007","unstructured":"Nelson RJ, Trainor BC. Neural mechanisms of aggression. Nat Rev Neurosci. 2007;8:536\u201346.","journal-title":"Nat Rev Neurosci"},{"key":"2508_CR118","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.avb.2008.06.003","volume":"13","author":"D Seo","year":"2008","unstructured":"Seo D, Patrick CJ, Kennealy PJ. Role of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disorders. Aggression Violent Behav. 2008;13:383\u201395.","journal-title":"Aggression Violent Behav"},{"key":"2508_CR119","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1017\/S109285291500019X","volume":"20","author":"DR Rosell","year":"2015","unstructured":"Rosell DR, Siever LJ. The neurobiology of aggression and violence. CNS Spectr. 2015;20:254\u201379.","journal-title":"CNS Spectr"},{"key":"2508_CR120","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1073\/pnas.98.3.1277","volume":"98","author":"S Chiavegatto","year":"2001","unstructured":"Chiavegatto S, Dawson VL, Mamounas LA, Koliatsos VE, Dawson TM, Nelson RJ. Brain serotonin dysfunction accounts for aggression in male mice lacking neuronal nitric oxide synthase. Proc Natl Acad Sci USA. 2001;98:1277\u201381.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2508_CR121","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0166-4328(01)00298-4","volume":"125","author":"KA Miczek","year":"2001","unstructured":"Miczek KA, Maxson SC, Fish EW, Faccidomo S. Aggressive behavioral phenotypes in mice. Behav Brain Res. 2001;125:167\u201381.","journal-title":"Behav Brain Res"},{"key":"2508_CR122","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1126\/science.8211186","volume":"262","author":"HG Brunner","year":"1993","unstructured":"Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science. 1993;262:578\u201380.","journal-title":"Science"},{"key":"2508_CR123","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0165-1781(00)00162-1","volume":"95","author":"SB Manuck","year":"2000","unstructured":"Manuck SB, Flory JD, Ferrell RE, Mann JJ, Muldoon MF. A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity. Psychiatry Res. 2000;95:9\u201323.","journal-title":"Psychiatry Res"},{"key":"2508_CR124","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/sj.mp.4001492","volume":"9","author":"JH Beitchman","year":"2004","unstructured":"Beitchman JH, Mik HM, Ehtesham S, Douglas L, Kennedy JL. MAOA and persistent, pervasive childhood aggression. Mol Psychiatry. 2004;9:546\u20137.","journal-title":"Mol Psychiatry"},{"key":"2508_CR125","doi-asserted-by":"publisher","first-page":"20120536","DOI":"10.1098\/rstb.2012.0536","volume":"368","author":"P Blier","year":"2013","unstructured":"Blier P, El Mansari M. Serotonin and beyond: therapeutics for major depression. Philos Trans R Soc Lond B Biol Sci. 2013;368:20120536.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2508_CR126","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/00042752-199501000-00005","volume":"5","author":"DA Malone Jr","year":"1995","unstructured":"Malone DA Jr, Dimeff RJ, Lombardo JA, Sample RH. Psychiatric effects and psychoactive substance use in anabolic-androgenic steroid users. Clin J Sport Med. 1995;5:25\u201331.","journal-title":"Clin J Sport Med"},{"key":"2508_CR127","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/MED.0000000000000404","volume":"25","author":"G Kanayama","year":"2018","unstructured":"Kanayama G, Kaufman MJ, Pope HG Jr. Public health impact of androgens. Curr Opin Endocrinol Diab Obes. 2018;25:218\u201323.","journal-title":"Curr Opin Endocrinol Diab Obes"},{"key":"2508_CR128","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1001\/jama.1989.03430220089036","volume":"262","author":"KB Kashkin","year":"1989","unstructured":"Kashkin KB, Kleber HD. Hooked on hormones? An anabolic steroid addiction hypothesis. JAMA. 1989;262:3166\u201370.","journal-title":"JAMA"}],"updated-by":[{"DOI":"10.1038\/s41386-026-02578-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000}}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02508-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02508-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02508-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:02:17Z","timestamp":1792479737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02508-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":128,"alternative-id":["2508"],"URL":"https:\/\/doi.org\/10.1038\/s41386-026-02508-w","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: \u201cThe first line in the second paragraph of Introduction is now revised to: When used recreationally, AAS are typically taken in 8\u201312-week cycles, often two to three times per year, at supraphysiological doses equivalent to approximately 250\u20135000 mg\/week\u2014approximately 5\u2013100 times greater than the natural male production of testosterone [8]. Moreover, a survey identifying trends in the nonmedical use of AAS revealed that almost 60% of the respondents reported using a weekly dose exceeding 1000 mg [Parkinson and Evans, 2006]. And accordingly this new reference is added: PARKINSON A, EVANS N. Anabolic Androgenic Steroids: A Survey of 500 Users Medicine & Science in Sports & Exercise. 2006;38:644-651\u201d.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41386-026-02578-w","URL":"https:\/\/doi.org\/10.1038\/s41386-026-02578-w","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AN, RS, and PEA are co-founders and shareholders in Tag-ON AB and are holding the patent \u2018Reactive desorption and\/or laser ablation ionization matrices and use thereof\u2019, no. PCT\/SE2019\/050197. The other authors declare no known competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}